• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ESRRG 启动子超甲基化作为喉鳞状细胞癌的诊断和预后生物标志物。

ESRRG promoter hypermethylation as a diagnostic and prognostic biomarker in laryngeal squamous cell carcinoma.

机构信息

Department of Otorhinolaryngology-Head and Neck Surgery, Lihuili Hospital of Ningbo University, Ningbo, China.

Department of Otolaryngology, Ningbo University Medical School, Ningbo, China.

出版信息

J Clin Lab Anal. 2019 Jul;33(6):e22899. doi: 10.1002/jcla.22899. Epub 2019 Apr 19.

DOI:10.1002/jcla.22899
PMID:31002184
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6642328/
Abstract

BACKGROUND

Estrogen-related receptor gamma (ESRRG) has been identified as a tumor suppressor gene in several cancers. We aimed to evaluate ESRRG promoter methylation in laryngeal squamous cell carcinoma (LSCC) and its relative clinical value in LSCC.

METHODS

Bisulfite pyrosequencing assays were performed on 91 pairs of tumor and paracancer tissues from LSCC patients in China. The diagnostic value and overall survival (OS) were analyzed descriptively by receiver operating characteristic (ROC) curves and the Kaplan-Meier methods, respectively.

RESULTS

The ESRRG promoter was more frequently hypermethylated in tumor tissues than in adjacent tissues (P < 0.01). ESRRG promoter methylation was significantly increased in advanced T stage tumors (P < 0.01) and advanced clinical stage patients (P < 0.01). Moreover, the area under the ROC curve (AUC) value (0.81) indicated high discrimination accuracy. Furthermore, ESRRG hypermethylation was associated with poor OS, as confirmed by Kaplan-Meier survival curves (P < 0.01).

CONCLUSION

Our study indicated that ESRRG promoter hypermethylation contributed to LSCC-related risks, primarily tumor progression and survival prognosis, in patients. ESRRG promoter methylation could, therefore, be a diagnostic and prognostic biomarker in LSCC.

摘要

背景

雌激素相关受体 γ(ESRRG)已被确定为几种癌症中的肿瘤抑制基因。我们旨在评估 ESRRG 启动子甲基化在喉鳞状细胞癌(LSCC)中的作用及其在 LSCC 中的相对临床价值。

方法

在中国 91 对 LSCC 患者的肿瘤和癌旁组织中进行了亚硫酸氢盐焦磷酸测序分析。通过接收者操作特征(ROC)曲线和 Kaplan-Meier 方法分别对诊断价值和总生存期(OS)进行描述性分析。

结果

肿瘤组织中 ESRRG 启动子的超甲基化频率明显高于邻近组织(P<0.01)。ESRRG 启动子甲基化在晚期 T 分期肿瘤(P<0.01)和晚期临床分期患者中显著增加(P<0.01)。此外,ROC 曲线下面积(AUC)值(0.81)表明具有较高的区分准确性。此外,Kaplan-Meier 生存曲线证实 ESRRG 高甲基化与较差的 OS 相关(P<0.01)。

结论

我们的研究表明,ESRRG 启动子甲基化有助于患者的 LSCC 相关风险,主要是肿瘤进展和生存预后。因此,ESRRG 启动子甲基化可以作为 LSCC 的诊断和预后生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce96/6642328/dfc9e3e9ea8a/JCLA-33-e22899-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce96/6642328/af0fb5782b50/JCLA-33-e22899-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce96/6642328/deb82cd9c2ae/JCLA-33-e22899-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce96/6642328/dfc9e3e9ea8a/JCLA-33-e22899-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce96/6642328/af0fb5782b50/JCLA-33-e22899-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce96/6642328/deb82cd9c2ae/JCLA-33-e22899-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce96/6642328/dfc9e3e9ea8a/JCLA-33-e22899-g003.jpg

相似文献

1
ESRRG promoter hypermethylation as a diagnostic and prognostic biomarker in laryngeal squamous cell carcinoma.ESRRG 启动子超甲基化作为喉鳞状细胞癌的诊断和预后生物标志物。
J Clin Lab Anal. 2019 Jul;33(6):e22899. doi: 10.1002/jcla.22899. Epub 2019 Apr 19.
2
LZTS2 promoter hypermethylation: a potential biomarker for the diagnosis and prognosis of laryngeal squamous cell carcinoma.LZTS2 启动子超甲基化:喉鳞状细胞癌诊断和预后的潜在生物标志物。
World J Surg Oncol. 2018 Mar 2;16(1):42. doi: 10.1186/s12957-018-1349-y.
3
The Clinical Signification of Claudin-11 Promoter Hypermethylation for Laryngeal Squamous Cell Carcinoma.Claudin-11 启动子高甲基化在喉鳞状细胞癌中的临床意义。
Med Sci Monit. 2017 Jul 26;23:3635-3640. doi: 10.12659/msm.904751.
4
Promoter hypermethylation of miR-34a contributes to the risk, progression, metastasis and poor survival of laryngeal squamous cell carcinoma.miR-34a的启动子高甲基化与喉鳞状细胞癌的风险、进展、转移及不良预后相关。
Gene. 2016 Nov 30;593(2):272-6. doi: 10.1016/j.gene.2016.07.047. Epub 2016 Jul 20.
5
Promoter Methylation Is a Potential Diagnostic and Prognostic Biomarker for Laryngeal Squamous Cell Carcinoma.启动子甲基化是喉鳞状细胞癌潜在的诊断和预后生物标志物。
Biomed Res Int. 2017;2017:9058749. doi: 10.1155/2017/9058749. Epub 2017 Feb 16.
6
SSTR2 promoter hypermethylation is associated with the risk and progression of laryngeal squamous cell carcinoma in males.生长抑素受体2(SSTR2)启动子高甲基化与男性喉鳞状细胞癌的风险及进展相关。
Diagn Pathol. 2016 Jan 22;11:10. doi: 10.1186/s13000-016-0461-y.
7
Positive BCL2L12 expression predicts favorable prognosis in patients with laryngeal squamous cell carcinoma.BCL2L12 阳性表达可预测喉鳞状细胞癌患者的预后良好。
Cancer Biomark. 2019;25(2):141-149. doi: 10.3233/CBM-181772.
8
Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.喉鳞状细胞癌中死亡相关蛋白激酶基因的甲基化相关沉默
Laryngoscope. 2005 Aug;115(8):1395-401. doi: 10.1097/01.MLG.0000166708.23673.3A.
9
[Study of mRNA expression level and hypermethylation of CHFR promoter in the laryngeal squamous cell carcinoma tissue].喉鳞状细胞癌组织中CHFR启动子的mRNA表达水平及高甲基化研究
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2010 Aug;24(15):673-7.
10
LMX1B mRNA expression and its gene body CpG methylation are valuable prognostic biomarkers for laryngeal squamous cell carcinoma.LMX1B mRNA 表达及其基因体 CpG 甲基化是喉鳞状细胞癌有价值的预后生物标志物。
Biomed Pharmacother. 2019 Sep;117:109174. doi: 10.1016/j.biopha.2019.109174. Epub 2019 Jul 8.

引用本文的文献

1
Estrogen and bacterial infection.雌激素与细菌感染。
Front Immunol. 2025 Apr 29;16:1556683. doi: 10.3389/fimmu.2025.1556683. eCollection 2025.
2
A 15-Gene-Based Risk Signature for Predicting Overall Survival in SCLC Patients Who Have Undergone Surgical Resection.一种基于15个基因的风险特征用于预测接受手术切除的小细胞肺癌患者的总生存期。
Cancers (Basel). 2023 Oct 30;15(21):5219. doi: 10.3390/cancers15215219.
3
Translocation of Methionine Adenosyl Transferase MAT2A and Its Prognostic Relevance for Liver Hepatocellular Carcinoma.

本文引用的文献

1
Aberrant methylation and downregulation of ZNF667-AS1 and ZNF667 promote the malignant progression of laryngeal squamous cell carcinoma.ZNF667-AS1 和 ZNF667 的异常甲基化和下调促进喉鳞状细胞癌的恶性进展。
J Biomed Sci. 2019 Jan 26;26(1):13. doi: 10.1186/s12929-019-0506-0.
2
Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1.启动子甲基化调控的 miR-145-5p 通过靶向 FSCN1 抑制喉鳞状细胞癌进展。
Mol Ther. 2019 Feb 6;27(2):365-379. doi: 10.1016/j.ymthe.2018.09.018. Epub 2018 Sep 27.
3
Methylation status of KLF4 and HS3ST2 genes as predictors of endometrial cancer and hyperplastic endometrial lesions.
甲硫氨酸腺苷转移酶 MAT2A 的易位及其对肝癌的预后意义。
Int J Mol Sci. 2023 May 22;24(10):9103. doi: 10.3390/ijms24109103.
4
Identification of Potential Biomarkers Using Integrative Approach: A Case Study of ESCC.使用综合方法鉴定潜在生物标志物:以食管癌为例
SN Comput Sci. 2023;4(2):114. doi: 10.1007/s42979-022-01492-4. Epub 2022 Dec 21.
5
Correlation between DNA Methylation and Cell Proliferation Identifies New Candidate Predictive Markers in Meningioma.DNA甲基化与细胞增殖之间的相关性确定了脑膜瘤新的候选预测标志物。
Cancers (Basel). 2022 Dec 17;14(24):6227. doi: 10.3390/cancers14246227.
6
Prognostic and therapeutic prediction by screening signature combinations from transcriptome-methylome interactions in oral squamous cell carcinoma.通过筛选口腔鳞状细胞癌转录组-甲基化组相互作用中的特征组合进行预后和治疗预测。
Sci Rep. 2022 Jul 6;12(1):11400. doi: 10.1038/s41598-022-15534-7.
7
Epigenetic Study of Esophageal Carcinoma Based on Methylation, Gene Integration and Weighted Correlation Network Analysis.基于甲基化、基因整合和加权相关网络分析的食管癌表观遗传学研究
Onco Targets Ther. 2021 May 13;14:3133-3149. doi: 10.2147/OTT.S298620. eCollection 2021.
8
Tissue engineering of the larynx: A contemporary review.喉组织工程:当代综述。
J Clin Lab Anal. 2021 Feb;35(2):e23646. doi: 10.1002/jcla.23646. Epub 2020 Dec 15.
9
Integrated Analysis of a Risk Score System Predicting Prognosis and a ceRNA Network for Differentially Expressed lncRNAs in Multiple Myeloma.预测多发性骨髓瘤预后的风险评分系统与差异表达lncRNA的ceRNA网络的综合分析
Front Genet. 2020 Aug 27;11:934. doi: 10.3389/fgene.2020.00934. eCollection 2020.
10
Circular RNA Expression Profiles in Nasopharyngeal Carcinoma by Sequence Analysis.通过序列分析对鼻咽癌中环状RNA表达谱的研究
Front Oncol. 2020 Apr 30;10:601. doi: 10.3389/fonc.2020.00601. eCollection 2020.
KLF4 和 HS3ST2 基因甲基化状态作为子宫内膜癌和增生性子宫内膜病变的预测因子。
Int J Mol Med. 2018 Dec;42(6):3318-3328. doi: 10.3892/ijmm.2018.3872. Epub 2018 Sep 12.
4
Integrative Epigenetic and Gene Expression Analysis of Renal Tumor Progression to Metastasis.整合表观遗传和基因表达分析在肾癌转移进展中的作用
Mol Cancer Res. 2019 Jan;17(1):84-96. doi: 10.1158/1541-7786.MCR-17-0636. Epub 2018 Aug 21.
5
Survival and prognostic analysis of preoperative inflammatory markers in patients undergoing surgical resection for laryngeal squamous cell carcinoma.术前炎症标志物对行手术切除的喉鳞状细胞癌患者的生存和预后分析。
BMC Cancer. 2018 Aug 13;18(1):816. doi: 10.1186/s12885-018-4730-x.
6
Downregulation of gene expression in laryngeal squamous cell carcinoma is an effect of DNA hypermethylation and correlates with disease progression.喉鳞状细胞癌中基因表达的下调是DNA高甲基化的结果,且与疾病进展相关。
Am J Cancer Res. 2018 Jul 1;8(7):1249-1261. eCollection 2018.
7
The importance of stool DNA methylation in colorectal cancer diagnosis: A meta-analysis.粪便 DNA 甲基化在结直肠癌诊断中的重要性:一项荟萃分析。
PLoS One. 2018 Jul 19;13(7):e0200735. doi: 10.1371/journal.pone.0200735. eCollection 2018.
8
Telomerase reverse transcriptase regulates DNMT3B expression/aberrant DNA methylation phenotype and AKT activation in hepatocellular carcinoma.端粒酶逆转录酶调节肝细胞癌中 DNMT3B 的表达/异常 DNA 甲基化表型和 AKT 激活。
Cancer Lett. 2018 Oct 10;434:33-41. doi: 10.1016/j.canlet.2018.07.013. Epub 2018 Jul 11.
9
MicroRNA-1469, a p53-responsive microRNA promotes Genistein induced apoptosis by targeting Mcl1 in human laryngeal cancer cells.miRNA-1469 是一种 p53 反应性 microRNA,通过靶向人喉癌细胞中的 Mcl1 促进染料木黄酮诱导的细胞凋亡。
Biomed Pharmacother. 2018 Oct;106:665-671. doi: 10.1016/j.biopha.2018.07.005. Epub 2018 Jul 11.
10
A phase II randomized trial comparing neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in advanced squamous cell carcinoma of the pharynx or larynx.一项比较新辅助化疗后同期放化疗与单纯同期放化疗在晚期咽或喉鳞癌中疗效的 II 期随机试验。
Biomed J. 2018 Apr;41(2):129-136. doi: 10.1016/j.bj.2018.04.003. Epub 2018 May 21.